JP2024539222A5 - - Google Patents

Info

Publication number
JP2024539222A5
JP2024539222A5 JP2024523916A JP2024523916A JP2024539222A5 JP 2024539222 A5 JP2024539222 A5 JP 2024539222A5 JP 2024523916 A JP2024523916 A JP 2024523916A JP 2024523916 A JP2024523916 A JP 2024523916A JP 2024539222 A5 JP2024539222 A5 JP 2024539222A5
Authority
JP
Japan
Prior art keywords
compound
tautomer
alkyl
groups
stereoisomer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024523916A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024539222A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/CN2022/127233 external-priority patent/WO2023072026A1/en
Publication of JP2024539222A publication Critical patent/JP2024539222A/ja
Publication of JP2024539222A5 publication Critical patent/JP2024539222A5/ja
Pending legal-status Critical Current

Links

JP2024523916A 2021-10-25 2022-10-25 Sarm1調節物質、その調製、及び使用 Pending JP2024539222A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CN2021125941 2021-10-25
CNPCT/CN2021/125941 2021-10-25
PCT/CN2022/127233 WO2023072026A1 (en) 2021-10-25 2022-10-25 Sarm1 modulators, preparations, and uses thereof

Publications (2)

Publication Number Publication Date
JP2024539222A JP2024539222A (ja) 2024-10-28
JP2024539222A5 true JP2024539222A5 (enExample) 2025-10-29

Family

ID=86160472

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024523916A Pending JP2024539222A (ja) 2021-10-25 2022-10-25 Sarm1調節物質、その調製、及び使用

Country Status (7)

Country Link
US (1) US20250236613A1 (enExample)
EP (1) EP4423067A4 (enExample)
JP (1) JP2024539222A (enExample)
CN (1) CN118176181A (enExample)
CA (1) CA3232341A1 (enExample)
IL (1) IL311604A (enExample)
WO (1) WO2023072026A1 (enExample)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2026086928A1 (en) * 2024-10-25 2026-04-30 Sironax Ltd. Sarm1 modulators, preparations, and uses thereof

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2018057989A1 (en) * 2016-09-24 2018-03-29 Washington University INHIBITORS OF SARM1 NADase ACTIVITY AND USES THEREOF
WO2019165159A1 (en) * 2018-02-23 2019-08-29 Oxalurx, Inc. Compounds and methods for treating oxalate-related diseases
CN112955150A (zh) * 2018-10-19 2021-06-11 达萨玛治疗公司 与nad+或nad+前体组合的sarm1抑制剂
CA3124700A1 (en) * 2018-12-31 2020-07-09 Icahn School Of Medicine At Mount Sinai Kinase inhibitor compounds and compositions and methods of use
WO2020252229A2 (en) * 2019-06-14 2020-12-17 Disarm Therapeutics, Inc. Inhibitors of sarm1
US12441719B2 (en) * 2019-09-12 2025-10-14 Disarm Therapeutics, Inc. Inhibitors of SARM1

Similar Documents

Publication Publication Date Title
JP2024543976A5 (enExample)
JP2024543975A5 (enExample)
JP2024514837A5 (enExample)
JP2022534426A5 (enExample)
JP2010501587A5 (enExample)
JP2025512474A5 (enExample)
JP2020526561A5 (enExample)
CN114072396A (zh) 作为dna-pk抑制剂的喹啉和噌啉衍生物
JP2010517946A5 (enExample)
JP2019512485A5 (enExample)
RU2004117887A (ru) Ариланилиновые агонисты бета2 адренергических рецепторов
RU2001114978A (ru) N-ариламиды антраниловой кислоты и тиоантраниловой кислоты
BRPI0507506A (pt) compostos
JP2009528273A5 (enExample)
JP2011509309A5 (enExample)
JP2016518434A5 (enExample)
JP2006515858A5 (enExample)
JP2022108241A5 (enExample)
CA2331460A1 (en) Heterocyclic inhibitors of p38
JP2010523653A5 (enExample)
JP2021510733A5 (enExample)
RU2006122661A (ru) Диазаиндолдикарбониллиперазинильные противовирусные агенты
JP2024544060A5 (enExample)
JP2024537394A5 (enExample)
JP2023512664A5 (enExample)